Effect of a pharmacist-led mHealth app on adherence, quality of life, and glycaemic control in diabetes: A multicentre RCT.
Mohd Syamir Mohamad Shukeri, Baharudin Ibrahim, Siew Chin Ong et al.
✦ AI-curated · Sources linked
In 30 seconds
This multicentre randomized controlled trial evaluated the impact of the CareAide® mHealth app on medication adherence, quality of life, and glycaemic control in 663 patients with type 2 diabetes. The study found significant improvements in adherence (MMAS-8: 7.31 vs 5.55) and quality of life (AQoL-6D: 0.669 vs 0.618), while glycaemic control showed a non-significant trend (HbA1c: -0.41%, p=0.002) requiring cautious interpretation.
Key findings
- CareAide® improved medication adherence significantly (MMAS-8: 7.31 vs 5.55, d=1.64; p<0.001).
- Proportion of Days Covered (PDC) ≥80% was achieved by 81.6% of participants compared to 33.0% (p<0.001).
- Quality of life improved significantly (AQoL-6D: 0.669 vs 0.618, d=0.353, p<0.001).
- Glycaemic control showed a significant difference in baseline-adjusted ANCOVA (HbA1c: -0.41%, p=0.002).
Why it matters
Improving medication adherence and quality of life in diabetes management is crucial for enhancing patient outcomes. This study highlights the potential of mHealth interventions, like CareAide®, to support patients effectively.